← Back to Search

Exercise Timing for Type 2 Diabetes

N/A
Recruiting
Led By Steven K Malin, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects currently taking medications that affect heart rate and rhythm (i.e. Ca++ channel blockers, nitrates, alpha- or beta-blockers)
Male or female >30 and <70 years old
Must not have
Evidence of type 1 diabetes and diabetics requiring insulin therapy
Currently taking active weight suppression medication (e.g. phentermine,orlistat, lorcaserin, naltrexone-bupropion in combination, liraglutide, benzephetamine, diethylpropion, phendimetrazine)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over the course of 2 weeks.
Awards & highlights

Summary

This trial will test whether Noom, a weight-loss app, helps people with type 2 diabetes better stick to their exercise and diet plan, leading to more weight loss and better health.

Who is the study for?
Adults aged 30-70 with type 2 diabetes, a BMI between 28 and 45, not currently on weight loss meds or insulin therapy. Mustn't have significant heart, liver, kidney diseases or cancer. Non-smokers only (or those who quit over a year ago), not pregnant/nursing, and haven't been exercising regularly.
What is being tested?
The trial is testing the effectiveness of Noom for improving diet adherence during exercise in the morning vs. afternoon for better weight loss and heart health in type 2 diabetics. It's checking if this leads to better blood sugar control and blood pressure.
What are the potential side effects?
Since this study involves lifestyle changes rather than medication, side effects may include typical exercise-related issues such as muscle soreness or fatigue but are generally minimal compared to drug interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently on medication that affects my heart rate or rhythm.
Select...
I am between 30 and 70 years old.
Select...
I have been diagnosed with type 2 diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have type 1 diabetes and need insulin.
Select...
I am currently on medication to help with weight loss.
Select...
I am currently smoking or quit less than a year ago.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over the course of 2 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and over the course of 2 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Body Weight
Secondary study objectives
Flow-mediated dilation
Glucose Tolerance

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise MorningExperimental Treatment2 Interventions
If subjects are randomly assigned to this group, they will participate in exercise training in the morning at a moderate to hard intensity. Subjects will be asked to regularly engage in morning exercise while supervised for about 2 weeks.
Group II: Exercise AfternoonActive Control1 Intervention
If subjects are assigned to this group, they will participate in the same exercise program but after in the afternoon.

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
440 Previous Clinical Trials
65,352 Total Patients Enrolled
3 Trials studying Metabolic Syndrome
220 Patients Enrolled for Metabolic Syndrome
Noom Inc.Industry Sponsor
15 Previous Clinical Trials
2,398 Total Patients Enrolled
Steven K Malin, PhDPrincipal InvestigatorRutgers University - New Brunswick
4 Previous Clinical Trials
252 Total Patients Enrolled
2 Trials studying Metabolic Syndrome
152 Patients Enrolled for Metabolic Syndrome

Media Library

Exercise Afternoon Clinical Trial Eligibility Overview. Trial Name: NCT05108987 — N/A
Metabolic Syndrome Research Study Groups: Exercise Morning, Exercise Afternoon
Metabolic Syndrome Clinical Trial 2023: Exercise Afternoon Highlights & Side Effects. Trial Name: NCT05108987 — N/A
Exercise Afternoon 2023 Treatment Timeline for Medical Study. Trial Name: NCT05108987 — N/A
~3 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top